 GSK615915A is being developed as a novel surfactant for use in the formulation of GSKs future generation of Metered Dose Inhalers MDIs. A surfactant in a MDI would provide a more stable drug suspension, this in turn will produce a consistent dose of drug being delivered with each puff. 